T1	CHEM 9 20	Inmunoferón
#1	AnnotatorNotes T1	C0063415; Immunoferon; Pharmacologic Substance
T2	PROC 27 38	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	PROC 415 431	Se aleatorizaron
#3	AnnotatorNotes T3	C0034656; Randomization; Research Activity
T4	DISO 45 74	estomatitis aftosa recurrente
#4	AnnotatorNotes T4	C2937365; Recurrent aphthous ulcer; Disease or Syndrome
T5	PROC 99 160	ensayo clínico terapeútico aleatorizado, controlado, fase III
#5	AnnotatorNotes T5	C0282461; Phase 3 Clinical Trials; Research Activity + C0206035; Controlled Clinical Trials, Randomized; Research Activity
T6	DISO 196 225	estomatitis aftosa recurrente
#6	AnnotatorNotes T6	C2937365; Recurrent aphthous ulcer; Disease or Syndrome
T7	PROC 321 337	consulta externa
#7	AnnotatorNotes T7	C0199298; outpatient consultation; Health Care Activity
T8	PROC 447 458	tratamiento
#8	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	CHEM 478 487	vitaminas
#9	AnnotatorNotes T9	C0042890; Vitamins; Organic Chemical · Pharmacologic Substance · Vitamin
T10	CHEM 492 518	colutorios de clorhexidina
#10	AnnotatorNotes T10	C0352155; Chlorhexidine Mouthwash; Clinical Drug
T11	PROC 540 551	tratamiento
#11	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	CHEM 565 576	Inmunoferón
#12	AnnotatorNotes T12	C0063415; Immunoferon; Pharmacologic Substance
T13	DISO 583 591	lesiones
#13	AnnotatorNotes T13	C0221198; Lesion; Finding
T14	DISO 662 672	enfermedad
#14	AnnotatorNotes T14	C0012634; Disease; Disease or Syndrome
T15	DISO 824 834	enfermedad
#15	AnnotatorNotes T15	C0012634; Disease; Disease or Syndrome
T16	DISO 1307 1341	reacciones adversas al medicamento
#16	AnnotatorNotes T16	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T17	CHEM 1330 1341	medicamento
#17	AnnotatorNotes T17	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T18	LIVB 78 83	niños
#18	AnnotatorNotes T18	C0008059; Child; Age Group
T19	LIVB 166 175	pacientes
#19	AnnotatorNotes T19	C0030705; Patients; Patient or Disabled Group
T20	Age 176 190	de 1 a 18 años
T22	Date 371 390	septiembre del 2003
T23	Date 393 412	septiembre del 2004
T24	LIVB 699 704	niños
#20	AnnotatorNotes T24	C0008059; Child; Age Group
T25	Duration 848 857	10,5 días
T26	Duration 860 868	6,2 días
T28	LIVB 1150 1159	pacientes
#21	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	Duration 1202 1227	por encima de los 3 meses
T30	Neg_cue 1299 1301	No
T21	Duration 894 898	10,6
T31	Duration 901 904	8,3
T32	LIVB 911 918	control
#22	AnnotatorNotes T32	C0009932; Control Groups; Group
T33	LIVB 469 476	control
#23	AnnotatorNotes T33	C0009932; Control Groups; Group
T27	LIVB 875 888	grupo estudio
#24	AnnotatorNotes T27	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T34	LIVB 531 538	estudio
#25	AnnotatorNotes T34	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T35	DISO 1193 1201	recidiva
#26	AnnotatorNotes T35	C2825055; Recurrence (disease attribute); Pathologic Function
A1	Population_data T18 Age
A2	Population_data T24 Age
A3	Assertion T16 Negated
R1	Negation Arg1:T30 Arg2:T16	
R2	Causes Arg1:T17 Arg2:T16	
R3	Used_for Arg1:T1 Arg2:T2	
R4	Experiences Arg1:T18 Arg2:T4	
R5	Experiences Arg1:T18 Arg2:T1	
R6	Has_Age Arg1:T19 Arg2:T20	
R7	Experiences Arg1:T19 Arg2:T6	
R8	After Arg1:T5 Arg2:T22	
R9	Before Arg1:T5 Arg2:T23	
R10	Before Arg1:T3 Arg2:T8	
R11	Before Arg1:T3 Arg2:T9	
R12	Before Arg1:T3 Arg2:T12	
R13	Experiences Arg1:T34 Arg2:T11	
R14	Used_for Arg1:T12 Arg2:T11	
R16	Experiences Arg1:T33 Arg2:T9	
R17	Combined_with Arg1:T9 Arg2:T10	
R18	Experiences Arg1:T33 Arg2:T8	
R19	Experiences Arg1:T34 Arg2:T8	
T37	Quantifier_or_Qualifier 611 616	menor
R20	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T37	
T38	Quantifier_or_Qualifier 627 639	herpetiforme
#27	AnnotatorNotes T38	C4476693; Herpetiform; Spatial Concept
R21	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T38	
T39	Quantifier_or_Qualifier 618 623	mayor
#28	AnnotatorNotes T39	C0205164; Major; Qualitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T39	
#29	AnnotatorNotes T37	C0205165; Minor (value); Qualitative Concept
T40	Quantifier_or_Qualifier 650 655	menor
#30	AnnotatorNotes T40	C0205165; Minor (value); Qualitative Concept
R23	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T40	
T41	Quantifier_or_Qualifier 749 754	mayor
T42	Quantifier_or_Qualifier 791 803	herpetiforme
#31	AnnotatorNotes T42	C4476693; Herpetiform; Spatial Concept
#32	AnnotatorNotes T41	C0205164; Major; Qualitative Concept
R24	Has_Duration_or_Interval Arg1:T15 Arg2:T25	
R25	Has_Duration_or_Interval Arg1:T15 Arg2:T26	
R26	Experiences Arg1:T27 Arg2:T15	
R27	Experiences Arg1:T32 Arg2:T15	
R28	Has_Duration_or_Interval Arg1:T15 Arg2:T21	
R29	Has_Duration_or_Interval Arg1:T15 Arg2:T31	
T43	Observation 962 977	buena evolución
#33	AnnotatorNotes T43	C0184511; Improved; Finding (?)
T44	Quantifier_or_Qualifier 1019 1024	mayor
#34	AnnotatorNotes T44	C0205164; Major; Qualitative Concept
T45	Observation 1071 1086	mejoría clínica
#35	AnnotatorNotes T45	C0184511; Improved; Finding (?)
R30	Experiences Arg1:T28 Arg2:T35	
R31	Has_Duration_or_Interval Arg1:T35 Arg2:T29	
T46	CONC 968 977	evolución
#36	AnnotatorNotes T46	C0449259; Clinical course; Temporal Concept
T47	CONC 1041 1050	evolución
#37	AnnotatorNotes T47	C0449259; Clinical course; Temporal Concept
T48	Quantifier_or_Qualifier 1035 1040	mejor
R32	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T48	
#38	AnnotatorNotes T48	C0332272; Better; Qualitative Concept
R33	After Arg1:T7 Arg2:T22	
R34	Before Arg1:T7 Arg2:T23	
R35	After Arg1:T6 Arg2:T22	
R36	Before Arg1:T6 Arg2:T23	
T49	Quantifier_or_Qualifier 705 718	de mayor edad
R37	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T49	
T50	Quantifier_or_Qualifier 761 774	de menor edad
R38	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T50	
#39	AnnotatorNotes T49	[(?) It could be Age]
#40	AnnotatorNotes T50	[(?) It could be Age]
T51	LIVB 437 458	grupos de tratamiento
R39	Experiences Arg1:T51 Arg2:T8	
#41	AnnotatorNotes T51	C5205742; Treatment Group; Population Group
R40	Experiences Arg1:T51 Arg2:T3	
R41	Experiences Arg1:T19 Arg2:T7	
A4	Experiencer T18 Patient
A5	Experiencer T19 Patient
A6	Experiencer T51 Patient
A7	Experiencer T33 Patient
A8	Experiencer T34 Patient
A9	Experiencer T24 Patient
A10	Experiencer T27 Patient
A11	Experiencer T32 Patient
A12	Experiencer T28 Patient
